Pharmaceutical Technology26m
Health Canada approves GSK’s Ojjaara for myelofibrosis in anaemia patients
Health Canada has granted approval for GlaxoSmithKline’s ( GSK) Ojjaara (momelotinib) for treating myelofibrosis (MF) in ...
Natera, Inc. (NASDAQ:NTRA) Q3 2024 Earnings Call Transcript
Q3 2024 Earnings Call Transcript November 12, 2024 Operator: Welcome to Natera’s 2024 Third Quarter Financial Results ...
Mersana Therapeutics, Inc.: Mersana Therapeutics Provides Business Update and Announces Third Quarter 2024 Financial Results
Plan to announce initial clinical data for XMT-1660 at a company event by the end of 2024 Dose escalation advancing in Phase 1 clinical trial of XMT-2056 Conference call today at 8:00 a.m. ET CAMBRIDG ...
There are now 5,000 ISA millionaires! See the surprising UK dividend shares they’re buying
The number of ISA millionaires is growing all the time and guess what? They're really into blue-chip dividend shares listed on the FTSE 100 index, says Harvey Jones. The post There are now 5,000 ISA ...